Online Only Articles

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies

Department of Pathology and Immunology
Department of Pathology and Immunology
Department of Pathology and Immunology
Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA
Vol. 104 No. 8 (2019): August, 2019 https://doi.org/10.3324/haematol.2018.205302